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Cancer treatment has raised many drugs and radiation therapies whose side-effects are visible. Ongoing
research throughout theworld for effective treatmentmainly concentrates onmethods either in the form
of drugs or therapies against this lethal disease. However returning to ayurvedic roots enlightens the fact
that nature hasmany efﬁcient components with anti-cancerous, anti-proliferating and anti-angiogenesis
effects. Evidences conﬁrm the participation of plants extracts in synthesizing many medicines against
already existing and even emerging diseases. Structure activity relationship (SAR) studies and structural
modiﬁcations are helping in observing the basis of compounds characteristics to exhibit inhibitor’s
nature against carcinogenic agents bymodifying parent compounds for creating an improved and potent
compound. Many components are under clinical trials but most of them still need attention. In this
reviewan attempt has beenmade to focus on the natural components gifted by nature and even included
in our diet with their structures and sources that could be supportive in designing drug either by
computational methods or by experimental methods.
ã 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
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Most primitive and effective method from pre-historic time to
heal injuries, cure disease and relieve suffering is treatment from
plants extract. Every part of plant from root to tip participates in
the production of drugs against many diseases. According toWorld
Health Organization most lethal and leading cause of death
worldwide accounting for 7.6 million deaths (13% of all deaths) in
2008 is Cancer. Researchers use natural components, synthetic
compounds and even micro-organisms for making an active drug
with the capability to distinguish between healthy cells and tumor
cells. Though many natural compounds are under clinical trials yet
compounds with anti-cancerous activities still not under clinical
trial cannot be neglected
Tian Xian, sophora root, zedoania, rhubarb root and rhizome,
mistletoe, cleavers, sweet violet, hot pepper, capsaicin, neem,
country gooseberry, selaginella are some herbs still under
investigation for their active ingredient acting as anti-tumor
agents as well as for SAR studies.
2. Turmeric
For centuries in Indian subcontinent spice named Turmeric is
readily used as food ingredient as well as an ayurvedic medicine
[1]. The major anti-cancer compound in turmeric is curcumin
((1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-
3,5-dione) which has been able to suppressmany biological factors
responsible for the proliferation of cancer cells, for instance NF-kB,
IkBa kinase, by induction in apoptosis pathway through activation
of caspase-8, BID cleavage and cytochrome C release in human
lung, breast, prostate tumor cell lines and many myeloma cells
[2–8]. Further curcumin administration exerted a gradual deterio-
ration in tumor growth rate and gelatinolytic activities of matrix
metaloproteinase-9 with a signiﬁcant increase in animal survival
time.Moreover suppression of hemoglobin concentration in tumor
studies gave a clear indication of angiogenesis process inhibition.
Overall results conclude curcumin as the potent inhibitor for tumor
cells [9]. But due to poor absorption of curcumin in bloodstream
certain derivatives have been proposed which may help in
enhancing its bioavailability. Xu et al. in their studies during
2012, focus on structure–activity analysis between androgen
receptor and curcumin derivatives. They suggested that for getting
improved cytotoxic activitymodiﬁcations favors the presence of H-
bond acceptors (negatively charged) at R1, R2, R3 and R4 position,
hydrophobic substituents attached to linker, biphenyl rings at both
the sides and bulky groups at C-4 position of linker (Table 1) [10].
3. Ashwagandha
Ashwagandha has powerful antioxidant properties to seek as
well as to destroy free radical and simultaneously boost the activity
of antioxidant enzymes (for example superoxide dismutase and
catalase) in order to prevent adverse effect on nervous system.
Moreover in-vitro studies to treat many types of cancer cell lines
such as human breast, lung and colon cancer against common
cancer chemotherapy drugs gave comparable results thus proving
it as an anti-tumor agent. The compound active for anti-cancerous
property in this plant is withaferin A ((4b,5b,6b,22R)-4,
27-dihydroxy-5,6:22,26-diepoxyergosta-2,24-diene-1,26-dione)
[11–14]. Its property to inhibit angiogenesis and furthermore to act
as adjunct to chemotherapy treatment by protecting the gradual
deterioration in white blood cells called neutrophils without any
contrast, enlighten its performance as key step in ﬁghting cancer
[15–18]. Animal toxicity studies designate this astonishing plant
safe and well tolerated [19]. In-vitro studies of withaferin and its
derivatives on P388 cells performed by Fuska et al. predict throughSAR studies that dissociation of double bond at C2¼C3 position
shows notable decline in cytotoxicity in all derivatives. In addition
carbonyl group at C4 position results in enhancement of effect of
agent while no change in biological functions can be seen on
dissociation of double bond at C24¼C25 or on removal of OH group
from C27 (Table 1) [20]. Further Zhang et al. in search of bioactive
compounds isolated 29 withanolides and prepared derivatives
from them followed by anti-proliferation testing on array of cell
lines. Out of all 15 withanolides showed better anti-proliferactive
activity against various cell lines. From their own research and the
data obtained from literature it was concluded that 5b,6b-epoxy
group or 5a-chloro-6b-hydroxy function in ring B, conjugated
€2-1-oxo function in ring A and esteriﬁcation of hydroxyl group
enhances the cytotoxic effect of compound while presence of—OH
and —OR groups at C-4,7,11,12,14,15,16,17,18,19,20,23,24 and
27 does not have signiﬁcant role in improving the cytotoxic effect
of compound. They also suggest glycosylation of withanolide as a
reason decreased anti-proliferative action [21].
4. Honey
The book ‘Honey Revolution’ written by Dr. Ron Fessenden
states thatminute traces of ﬂoral bioﬂavonoids generally known as
antioxidants contribute majorly by raising antioxidant levels
within the cells [22]. Testing of honey as anti-cancerous agent is
yet in practice. Researchers found caffeic acid phenethyl ester
(CAPE) as active compound in bee propolis proﬁcient to inhibit
early-stages of prostate cancer. Its anti-mitogenic and anti-
carcinogenic characteristics were capable to inhibit NF-kB path-
ways in cancer cells. Experiments on tumor growth of LNCaP
xenografts in mice signiﬁcantly illustrated the results [23]. In
addition, preventive and curative effect of bee products on tumor
cells approves its anti-cancerous nature. SAR studies on CAPE
suggest the signiﬁcance of number of hydroxyl groups. The fact
was observed by replacing and adding hydroxyl groups in CAPE
structure. Interchange in position of hydroxyl group in CAPE from
3,4-dihydroxy to 2,5-dihydroxy resulted in enhancement of
potency while replacement of hydroxyl group with methyl ethers
and addition of third hydroxyl group resulted in loss of inhibiting
effect of compound. At the same point an increase in alkyl chain
proved to be an insigniﬁcant compound related to inhibitory effect
(Table 1) [24]. In addition to CAPE other polyphenols believed to be
effective against cancer disease are caffeic acid (CA), chrysin,
galangin, quercentin, kaempferol, acacetin, pinaocembrin, pino-
banksin and apigenin. Orsolic et al. in 2005 concluded the
signiﬁcant suppression activity of CA and CAPE on human HeLa
cervical tumor cell line through in-vitro experiments [25].
Chrysin (5,7-dihydroxy-2-phenyl-4H-chromen-4-one) is anoth-
er anti-cancer active compound in honey. Unfortunately its anti-
cancer characteristics have rarely been studied. Structural studies
showed that chrysin has similar structure toﬂavone structurewith a
difference of presence of two hydroxyl groups at position 5 and 7 at
ringA.These twohydroxyl groupswith2,3doublebondat ringCand
attachment of B and C rings at position 2 (Table 1) are considered as
the effective regions for apoptotic properties in certain human
cancercell lines likecervical cancer, leukemia, esophageal squamous
carcinoma, malignant glioma, breast carcinoma, prostate cancer,
non-small cell lung cancer and colon cancer while in many cases
lower potency rate have been noted. Many in-vitro experiments
demonstrated that instead of usingonly chrysin, eithermodiﬁcation
of chrysin or combination of chrysin with other ﬂavonoids could
improve the effectiveness of apoptotic factor [26]. In accordance to
Monasterio et al. the presence of at least two hydroxyl groups at
position 3, 5 or 7 in form of 3–5, 5–7 or 3–7, were needed for proper
apoptotic effect. The possibility was based on the comparison
betweenstructural similarityofchrysin,galanginandvarioussimilar
able 1
nti-cancer compounds with their source, structures and location.
Anti-cancerous agent Active compound Location
Name Structure
Turmeric (Curcuma
longa)
Curcumin
((1 E,6E)-1,7-bis(4-hydroxy-3-
methoxyphenyl)-1,6-heptadiene-3,5-dione)
South and Southeast Asia
Ashwagandha
(Withania somnifera)
Withaferin-A
((4b,5b,6b,22 R)-4,27-dihydroxy-5,6:22,26-
diepoxyergosta-2,24-diene-1,26-dione)
India, Pakistan, Afghanistan, Spain, parts of the
Middle East, Africa and the cancry Islands
Honey Caffeic acid phenethyl ester (CAPE)
(2-phenylethyl(2E)-3-(3,4-dihydroxyphenyl)
acrylate)
Worldwide
Garlic (Allium sativum) Diallysulﬁde
(4,5-dithia-1,7-octadiene) or
allylmethylsulﬁde
(3-(methylsulfanyl)-1-propene)
Native to central Asia, staple in the
Mediterranean region, frequent seasoning in
Africa, and Europe
Fruits Ellagic acid
(2,3,7,8-tetrahydroxychromeno[5,4,3-cde]
chromene-5,10-dione) (newly discovered in
red berries and pomegranate)
Worldwide
Red grape (Vitis
vinifera)
Resveratrol (3,5,40-trihydroxy-trans-stilbene) Native to the Mediterranean and Central Asia
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Table 1 (Continued)
Anti-cancerous agent Active compound Location
Name Structure
Tomato (Solanum
lycopersicum),
water-melon
(Citrullus lanatus),
guava (Psidium)
Lycopene
(c,c-carotene)
Native to South America and was spread
worldwide
Saffron (Crocus sativus) Crocetin
((2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-
tetramethyl-2,4,6,8,10,12,14-
hexadecaheptaenedioic acid)
Native to Southwest Asia was later brought to
parts of North Africa, North America, and
Oceania
Butterﬂy ginger
(Hedychium
coronarium)
Alpha terpineol
9 2-(4-methyl-3-cyclohexen-1-yl)-2-
propanol) and
[6]-gingerol ((5S)-5-hydroxy-1-(4-hydroxy-3-
methoxyphenyl)-3-decanone)
poly-phenolic constituents gingerols and
zerumbone
((2E,6E,10E)-2,6,9,9-tetramethyl-2,6,10-
cycloundecatrien-1-one)
Himalayas region of Nepal and India
Green Tea (Camellia
sinensis)
EGCG OR EGC [epigallocate-chin gallate]
((2S,3S)-5,7-dihydroxy-2-(3,4,5-
trihydroxyphenyl)-3,4-dihydro-2H-chromen-
3-yl 3,4,5-trihydroxybenzoate)
Native to China and other countries in the Orient,
Far East and India
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Table 1 (Continued)
Anti-cancerous agent Active compound Location
Name Structure
Grape Seeds (Vitis
vinifera)
Gallic acid
(3,4,5-trihydroxybenzoic acid)
FromWestern Europe to the Persian shores of the
Caspian Sea
Apricot kernels
(Prunus armeniaca)
Laetrile Europe, South Australia, central Asia and around
the Mediterranean
Corn (Zea mays) Ferulic acid
((2E)-3-(4-hydroxy-3-methoxyphenyl) acrylic
acid)
Native to the Balsas River valley in south-eastern
Mexico, Canada and the United States, Southern
Africa
Vegetables Sulforaphane
(1-isothiocyanato-4-(methylsulﬁnyl) butane)
Worldwide
Flex seeds (Linum
usitatissimum)
Lignans and an omega-3 fat called
alphalinolenic acid
Native to the region extending from the eastern
Mediterranean to India
Beet (Beta vulgaris) Betacyanin Throughout the Mediterranean, the Atlantic
coast of Europe, the Near East, and India
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Table 1 (Continued)
Anti-cancerous agent Active compound Location
Name Structure
Hop
(Humulus
lupulus)
Chalcones including xanthohumol Germany, UK, USA, Poland, China
Cats claw
(Uncaria
tomentosa)
Quinic acid
((1S,3R,4S,5R)-1,3,4,5-
tetrahydroxycyclohexanecarboxylic acid)
Found in the tropical jungles of South and
Central America
Maitake
mushrooms
(Grifola frondosa)
Irofulven ((60R)-60-hydroxy-30-
(hydroxymethyl)-20 ,40 ,60-trimethylspiro
[cyclopropane-1,50-inden]-70(60H)-one)
Native to the northeastern part of Japan and
North America
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Table 1 (Continued)
Anti-cancerous agent Active compound Location
Name Structure
Spirulina
(Arthrospira)
C-phycocyanin Worldwide
Red clover
(Trifolium
pratense)
Genistein
(5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-
chromen-4-one) [prevent angiogenesis]
Native to Europe, Western Asia and northwest
Africa, but planted and naturalised inmany other
regions
Tripterygium
(Tripterygium
wilfordii)
Celastrol
((2R,4aS,6aS,12bR,14aS,14bR)-10-hydroxy-
2,4a,6a,9,12b,14a-hexamethyl-11-oxo-
1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-
tetradecahydro-2-picenecarboxylic acid),
triterpene
China
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Table 1 (Continued)
Anti-cancerous agent Active compound Location
Name Structure
Marine natural
product
Lamellarins Marine region
Shark liver oil Alkylglycerols Ocean
Aloe vera Aloe-emodin
(1,8-dihydroxy-3-(hydroxymethyl)-9,10-
anthraquinone)
Worldwide
Saw plametto
(Serenoa
repens)
Beta-sitosterol
((3b)-stigmast-5-en-3-ol), stigmasterol
((3b,22 E)-stigmasta-5,22-dien-3-ol)
Endemic to the southeastern United States, along
the Atlantic and Gulf Coastal plains, southern
Arkansas, Florida
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Table 1 (Continued)
Anti-cancerous agent Active compound Location
Name Structure
Radium weed/
petty spurge/
cancer weed/
milk weed
(Euphorbia
peplus)
Ingenol mebutate
((1S,4S,5R,6R,9S,10R,12R,14R)-4,6-dihydroxy-
7-(hydroxymethyl)-3,11,11,14-tetramethyl-15-
oxotetracyclo[75,101,5010,12]pentadeca-2,7-
dien-5-yl (2 Z)-2-methyl-2-butenoate)
Australia, New Zealand, North America, and
other countries in temperate and sub-tropical
regions
Pau D’Arco
(Tabebuia)
Lapachol
(2-hydroxy-3-(3-methyl-2-buten-1-yl)-1,4-
naphthoquinone)
From northern Mexico and southern Florida
south to northern Argentina, Caribbean islands
of Puerto Rico, Hispaniola (Dominican Republic,
Haiti), Jamaica, Trinidad and Tobago and Cuba,
Brazil
Graviola
(Annona muricata)
Acetogenins Native to Mexico, Cuba, Central America, the
Caribbean and northern South America:
Colombia, Brazil, Peru, and Venezuela, sub-
Saharan African countries, some areas of
Southeast Asia as well as in some Paciﬁc islands
Chuchuhuasi
(Maytenus spp.)
Maytenin, maytansine
((4b,11E,13E)-maytansine)
Worldwide, commonly found in South America
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Table 1 (Continued)
Anti-cancerous agent Active compound Location
Name Structure
Wormwood
(Artemisia
absinthium)
Artemisinin
((4S,5R,8S,9R,12S,13R)-1,5,9-trimethyl-
11,14,15,16-tetraoxatetracyclo
[103,104,1308,13]hexadecan-10-one)
Native to temperate regions of Eurasia and
northern Africa
Mushrooms
(Agaricus
bisporus)
Active hexose correlated compound
(acetylated a-glucan, b-glucan)
Worldwide
Coffee Chlorogenic acid
((1S,3R,4R,5R)-3-{[(2E)-3-(3,4-
dihydroxyphenyl)-2-propenoyl]oxy}-1,4,5-
trihydroxycyclohexanecarboxylic acid)
Latin America, Southeast Asia, South Asia and
Africa
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Table 1 (Continued)
Anti-cancerous agent Active compound Location
Name Structure
Oldenlandia
(Oldenlandia diffusa)
Oleanolic acid its isomer ursolic acid, both
pentacyclic triterpenes
China
74 G. Kaur, N. Verma / Biotechnology Reports 6 (2015) 64–78compounds which differ only in positioning of hydroxyl group. The
conclusionwas formed after analyzing the better apoptotic activity
of 3,7-dihydroxyﬂavone, 5,7-dihydroxyﬂavone (chrysin), 3,5,
7-trihydroxyﬂavone (galangin) when compared with other com-
pounds i.e., 5-hydroxyﬂavone, 7-hydroxyﬂavone, 40,7-dihydroxy-
ﬂavone, and 7,8-naphtoﬂavone [27].
5. Garlic
With thestartingof1957, researcherswere involvedtodetermine
the facts in favor of garlic for treatment of cancer. Capability of garlic
extract to bring irregularities and to scatter the chromosomes in the
cancer cells introduced a new compound for treatment. Later,
reversed tumor development was not only seen in mice but also in
mammary tumors and sarcomas. Population consuming garlic and
cancer proliferation gave an inverse trend of overpowering cancer
development [28]. Most noteworthy evidences aroused from the
study performed on digestive tract tumors, for instance – gastric
cancer, stomach cancer, esophageal cancer and colorectal cancer
[29].Effectivenessof theextractcouldbeseeninnotonly fresh-garlic
extract but in aged-garlic extract as well [30]. Allium active
constitutes namely allysulﬁdes such as diallyldisulﬁde or allylme-
thyltrisulphide possibly relates to inhibit carcinogenesis by stimu-
lating Phase II conjugation systems and simultaneously enhancing
glutathione S-transferase (GST) which help in detoxifying carcino-
gen free-radicals.Moreover it assists the synthesisofDNA regulation
[31].Studiesrevealallylgroupof thiscompoundasfactorresponsible
for suppressing premalignant lesions caused by azoxymethane.
Inhibition in carcinogenic activity could be seen when single allyl-chain is linked to sulfur atom (Table 1). The compoundwas also able
to inhibit cytochrome p4502E1 (CYP2E1) isoform which is usually
believed to activatewide range of lowmolecularweight compounds
[32]. In 2010, Kaschula et al. worked on garlic derived organosulfur
compounds and suggested that lipid soluble anti-cancer agent in
crushed garlic, namely ajoene, diallyl sulﬁde, diallyl disulﬁde, diallyl
trisulﬁde are more potent as compared to water soluble
S-allylmercaptocysteine and S-allylcysteine. They also highlighted
common structural feature in ajoene and garlic-derived allyl sulﬁde
important factor responsible foranti-tumoractivity is allyl sulﬁdeor
polysulﬁde backbone. It was hypothesized that performance of this
group lies in vinyl disulﬁde core. Remarkably, in ajoene replacement
of allyl end group (sulfoxide end) with an alkyl or benzyl group
generated its analogs with improved or similar activity [33].
6. Fruits and vegetables
Ellagic acid being a natural phenolic antioxidant is consumed
throughmany fruits and vegetables. Inhibition of anti-proliferative
activity and induction of apoptosis involves the activation of
caspase cascade [34]. It is a planar molecule with skill to inhibit
CYP1A1-dependent activation of benzo[a]pyrene, DNA binding of
certain carcinogens and control various anticarcinogenic activities.
Ellagic acid has the property to inhibit CYPlAl-dependent
activation of benzo[a]pyrene thus in turn inhibiting polycyclic
aromatic hydrocarbon-induced tumorigenesis. Barch et al. dis-
cussed the importance of hydroxyl, lactone groups and 3-hydroxyl
and 4-hydroxyl group. They concluded that 4-hydroxyl group is
needed to inhibit CYP1A1-dependent activation of benzo[a]pyrene
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diolepoxide both 3-hydroxyl and 4-hydroxyl groups were essen-
tial. The facts were veriﬁed through study with ellagic acid and its
chemical analogs. (Table 1) [35].
7. Tomato
Lycopene is the carotene found in tomato. Consumption of
tomato highly drops the risk factors associated to reactive oxygen
species (ROS) mediated diseases. It is suggested that lycopene in
combination with other phytonutrients can gradually increase the
consequence to inhibit several pathways related to cancer cells
growth as well as interfere in mitogenic pathway of IGF-I [36,37].
Lycopene property to lack any electrophilic group gave similar
results in activation of electrophile/antioxidant response element
(EpRE/ARE) transcription system and in inhibiting breast and
prostate cancer cell growth as well. Linnewiel et al. used a series of
characterized mono as well as diapocarotenoids for displaying
results for EpRE/ARE. They recommendedmechanistic explanation
that aldehyde stimulate the activity at greater rate than acid when
apo-100-lycopenal (100-al), formed from single cleavage of lyco-
pene at the 90,100 double bond, was compared to apo-100-
lycopenoic acid. Secondly, there is direct correlation for activity
between number of methyl and aldehyde group on both sides of
molecule. Linnewiel et al. also studied reactivity of carotenoid
aldehyde derivatives through the combined effect of diapocar-
otene-dials with chain length of 8–12 carbon atoms. The results
revealed the correlation between methyl group and terminal
aldehyde. Methyl group at gamma or delta position enhances the
activity of molecule in cells (LNCap and MCF-7). Further the effect
of backbone chain was determined by comparing the activity of
derivatives with different numbers of carbon atoms. From which
12 carbon chain compound showed more potency as compared to
16 carbon chain compound displaying that the main chain of
molecule containing 12 carbon is optimal for inducing EpRE/ARE
transcription system. These results altogether could display
structural improvement positions for curing effect of carotenoid
(Table 1) [38]. Similar to lycopene, crocetin is also the oxygenated
form of carotenoids found in saffron and having anti-tumor
activity. Their mechanism includes inhibition of nucleic acid
synthesis, growth factor signaling pathway and induction of anti-
oxidative system and apoptosis [39].
8. Ginger
Use of ginger for medical treatment is popular practice in
eastern culture. It is underground rhizome with striated texture.
Researchers believe that ginger affect by two methods either
through apoptosis or autophagy and evidences associates it with
the cause to reduce colorectal and ovarian cancer. Moreover ginger
extract helps in reducing the NF-kB expression [40]. In study
performed by Dugasani et al. about comparison of antioxidant and
anti-inﬂammatory effect between gingerols and their derivatives
to determine the evaluation of scavenging of 1,1-diphenyl-2-
picyrlhydrazyl (DPPH), superoxide and hydroxyl radicals, inhibi-
tion ofN-formyl-methionyl-leucyl-phenylalanine induced reactive
oxygen species (ROS) construction in human polymorphonuclear
neutrophils, inhibition of lipopolysaccharide induced nitrite and
prostaglandin E creation in RAW264.7 cells, through SAR studies
demonstrated that a, b unsaturated ketone moiety could be the
reason for anti-inﬂammatory and anti-oxidant activity. However
the better potency of 10-gingerol instead of parent structure,
8-gingerol, 6-shogaol and 6-gingerol shows the signiﬁcant role of
chain length (Table 1) [41]. Also reverse docking studies performed
on [6]-gingerol with leukotriene A4 hydrolase (LTA4H) as target for
cancer therapy conﬁrmed that this compound has bindingsimilarities like bestatin (the aminopeptide inhibitor) which binds
to Glu271 residue of LTA4H. They supported their prediction by
testing and conﬁrming [6]-gingerol inhibitory effect on colorectal
cancer cells [42].
9. Pau d'arco
Pau d'arco, the inner bark or heartwood of a tropical member of
the bignonia family has been studied for its anti-inﬂammatory,
anti-cancer, antibacterial, antifungal, and immuno-stimulant
activities [43]. Lapachol as active ingredient in this bark was used
to perform SAR studies. Investigations done to synthesize
5-hydroxylapachol having anti-proliferative activity through
prenylation of 2-hydroxyjuglone uncovers the structure activity
relation of lapachol derivatives. Potency of molecule to suppress
tumor cell line depends on the presence and position of hydroxyl
group attached to the aromatic ring. This factor was conﬁrmed
after comparison between lapachol and its derivatives on human
solid tumor cells. A contrast study between hydroxyl groups at
carbon position 4, 5, 8 for anti-proliferative activity and fact that
presence of phenolic hydroxyl group at C-5 enhances the activity
prove the above result. Furthermore at one side the conversion of
free hydroxyl groups in the quinone ring tomethyl ethers results in
improvement in molecule's action while on the other side poorly
activated derivatives were produced when prenyl side chain was
removed. In addition a decrease in activity was due to the
replacement of the exocyclic double bond by an oxygenated
function (Table 1). So, conclusion proposes that both size and
relative position of side chain are essential for generation of a
modiﬁed compound with better activity [44].
10. Green tea
Polyphenols present in Green tea not only supresses the cancer
cell growth but also kill them after distinguishing tumor cells from
normal cells. Health ﬁlled characteristics have encouraged
researchers to work with Green tea compound EGCG having
anti-tumor and anti-angeogenic abilities. Scientists say that
number of proteins required for tumor suppression are degraded
by proteasome [45]. Many investigation studies regarding ECGC
suggests that although A-ring with gallate ester/amide bond are
essential for proteasome inhibition, the number of hydroxyl groups
associated with A, B or G ring are also important for enhancing
antitumor activity. More facts declares that hydroxyl groups
attached to the C-3 and C-4 position of G-ring also arises the
activity level of cytotoxicity (Table 1) [46–48].11. Vegetable
Consuming vegetables no doubt develop the immune system
and other essential components of body to ﬁght against various
diseases including cancer growth promoting factors. In order to
interpret SAR studies on sulforaphane (active ingredient in
vegetables) for high inducer properties racemic sulforaphane
and its derivatives different in position and number of oxidation
state of sulfur and methylene group were tested on murine
hepatoma cells. Additive effect of inducing glutathione transferase
and quinone reductase in certain mouse tissues was seen with
sulforaphane and its sulﬁde derivatives. Synthetic and isolated
sulforaphane gave approximate similar CD values showing that
chirality of sulfoxide does not affect its inducer values whereas
other factors like oxidation of the side chain sulﬁde to sulfoxide or
sulfone and compoundswith 4 or 5methylene groups in the bridge
linking CH3S— and —N¼C¼S enhances the potency level as
compared to three methylene group [49].
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Red clover is a fodder crop with nitrogen ﬁxing properties.
Besides this it is also taken to lab for having anti-cancer effect.
Genistein has been regarded as the anti-cancer compound in red
clover. Numerous studies on genistein have shown to affect many
biochemical targets like Protein tyrosine kinases, topoisomerase II,
estrogen receptor, ABC transporters, enzymes involved in phos-
phatidylinositol turnover etc. which are basically involved in
cancer progression pathway. Zava and Duwe investigated estro-
genic effect of genistein on MCF-7 cells and suggested that
40-hydroxy position on C-ring and 70-hydroxy position on A-ring
could be primary factors responsible for estrogenic activity. As
evidence it was seen that alteration made either as methylation at
40-hydroxy group or changing its conformation by shifting of
phenolic B ring from3- to 2- position bound onpyran ring, resulted
in drastic decrease in inhibitory activity. Indeed 5- hyroxyl and
4- ketonic oxygen groups were favorable too (Table 1) [50].
Moreover in case of genistein as PTK inhibitor Ogawara et al.
compared structure activity relationship against EGF-receptor
with certain isoﬂavonoids. They analyzed that removal of hydroxyl
group at position 5 is essential for proper functioning of the
compound. In addition genistein has also shown a capability
among (iso) ﬂavonoids to inhibit topoisomerase II [51].
13. Marine products
Marine products have also participated in healing process.
Researchers have been probing deep under the ocean to ﬁnd a
solution to various diseases. Some are found with anticancer
activity while others can reverse back multidrug resistance in
cancer cells. Lamellarins inhibit the P-glycoprotein whose mecha-
nism includes transporting anticancer agents out of cancer cells
and thus making them multidrug resistance [52]. SAR studies
concluded many positive and negative factors responsible for anti-
tumor activity of lamellarins. Firstly, positive factors includes
importance of double bond between C5¼C6 position as an
essential factor for anti-topoisomerase-I activity and —OH group
at C-8, C-14, C-20 position. Hydroxyl group at R1, R2 and R4 could
activate the cytotoxicity activity by DNA topoisomerase I inhibition
or kinase activity. Secondly discussing the negative factors,
hydroxyl attachment at R3, O-methylation at R6, replacing R1,
R3, R6 with O-isopropyl, saturation of double bond between
C-5 and C-6, methoxy group at C-13, C-12 and acetylation with
various carboxylic acids may leads to massive decline in
cytotoxicity level of compound. Furthermore an SAR investigation
led byUniversity of Queensland, Australia to evaluate cytotoxity, P-
glycoprotein inhibition and multidrug resistance reversal activity,
30 lamellarines and their derivatives identiﬁed through 2D
spectroscopywere utilized and thus reporting correlation between
P-glycoprotein inhibition and degree of methylation of lamellarin
hydroxyl groups. Although in human colon cancer cells highly
methylated compounds were capable of reversing multidrug
resistance yet less methylated compounds showed enhanced
cytotoxic activity (Table 1) [53–55].
14. Tripterygium wilfordii
From many years Tripterygium wilfordii has been used as
immunosuppressant. Bioactive components with high anti-tumor
activity are celastrol and triterpene. Celastrol is also designated as
proteasome inhibitor [56]. In case of celastrol studies performed
against topoisomerase II indicates that C-1 to C-10 and double
bond between C7¼C8 are essential while any modiﬁcations made
at C-6, C-21, C-22, C-23 position decreases the activity of apoptosis
shock response and inhibit Hsp90 and most of the time variationsmade at carboxylic acid by amide group functionality improved
potency of compound [57].
In case of triterpene, phosphatidylinositol speciﬁc phospholi-
pase C as target which leads to termination of DNA synthesis and
cell growth. Lee et al. presented their study which deals with
systematic structure activity relationship of triterpene ester
against PLCg1. Derivatives as acetate, methyl ester and reduced
form at 20double bond produced lower inhibitory effect when
compared to parent compound. Results suggested the presence of
3-OH, 70-OH, 28 COOH, 20 double bond and esteriﬁcation of
triterpene as important features for PLCg1 inhibitor. Moreover
3-OH, 27 esteriﬁcation, 28-COOH, 20double bond and p-coumar-
oyloxy at position 27 may be important for improved inhibitory
action (Table 1) [58,59].
15. Coffee
Most consumable beverage in world is coffee. The major
phenolic compound in coffee is chlorogenic acid which is an ester
of caffeic acid and quinic acid and makes it capable to absorb free
oxygen radicals [60]. SAR study has not been performed on this
compound yet.
16. Grape seeds
Studies performed on grape seed extract states that it brings
destruction in leukemic cells. Gallic acid is one of the cancer cells
suppressing agent. A study performed on anti-proliferative and
cytotoxic activity on HeLa cells presented the structural data on
methyl gallate, propyl gallate, octyl gallate and few other
polyphenol derivatives by theoretical (ab initio) approach. For
improved cytotoxic action of compound major factors includes
number of hydroxyl substituents on the ring and the side-chain
length between aromatic ring and terminal carboxylate group
(Table 1). The study concluded that a slight structural change in
derivatives have lead to improved biological activity. For instance
di- and trihydroxylated propyl esters produced distinct results
than parent methyl and octyl analogs when tested on cell line. Due
to effect of variation in length of the alkyl chain long alkyl chains
demonstrated an enhancement in activity while short alkyl chain
showed low antiproliferative activity. The study was emphasized
on properties like size, degree of ring hydroxyl substitution and
length of the alkyl chain. In addition, increase in chain length
increased the lipophilicity of compound which is also considered
as an important factor for drug designing [61–63].
17. Red grapes
Resveratrol (3,40,5-trihydroxystilbene) an anticancer agent
from red grapes prevents cancer by inhibiting cyclooxygenase
enzymes and angiogenesis with modulation of drug metabolizing
enzymes. Anti-oxidation, alterations in cell cycle and apoptotic
machinery simultaneously contribute in a process [64]. Compound
with respect to the growth of PC-3 and LNCaP human prostate
cancer cells have improved activity for anti-progressive activity.
SAR studies suggest the signiﬁcant presence of two methyl-oxyl
groups at position 3 and 5, N at 40 position and N¼C double bond in
the connecting chain as four analogs veriﬁed potent growth
inhibitory activity (IC50 0.01–0.04) in LNCaP cells [65]. Also N
replaced by a C— methoxy group decreases the activity while
replacement of—OH group tomethoxy group increases the activity
of compound. Cis-form showed higher cytotoxicity when com-
pared among its methoxylated analogs. A study performed to
conﬁrm the nature of series of methoxylated analogs of resveratrol
revealed that substitution of hydroxyl group with methoxy group
in resveratrol produced potential results in anti-tumor studies. In
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better potency in cis-form when compared to trans-isomers. In
case of hydroxylated resveratrol in trans-conformation hydroxyl
group at position 4- and 40 act as backbone of compound for anti-
tumor effect [66].
18. Maitake mushrooms
An active compound in maitake mushrooms is irofulven
(hydroxymethylacylfulvene). It mainly promotes the immune
system functioning and efﬁciency of related cells like natural
killer cells, cytotoxic T-cells, IL-1, IL-2, lymphokines etc. [67]. Its
unique property is to act as selective inducer of apoptosis in human
cancer cell lines. Facts disclose that active compound in mush-
rooms usually work by boosting the immune system. Irofulven
stimulates the activity of interleukin-2 mediated lymphokine-
activated killer cells and NK cells and instead of attacking directly
on cancer cells, immune system is activated. Although in 2001
Food and Drug Administration (FDA) approved irofulven as “fast
track” in gemcitabine-refractory pancreatic cancer cases but
unfortunately irofulven showed side effects of retinal damage
and visual disturbance in Phase II clinical trials due to which
investigation on this compoundwas seized [68]. So, to improve the
potency of compound and decrease its side-effect its structurally
modiﬁed analogs were tested.
Studies performed with analogs recommend that efﬁciency of
Irofulven as anti-tumor agent solely not only depends on free
allylic hydroxyl group but also on analog longer chain substituents,
followed by hydroxymethyl group (Table 1). It also shows
electrophiles, bioreductive activation, cyclopropane ring opening,
alkylation of protein and DNA as major factors for biological
activity [69]. McMorris et al. investigated on illudin S and M
analogs to ﬁnd compounds selective for normal and infected cells.
The key features concluded for anti-proliferative activity were
a,b-unsaturated ketones and cyclopropylmethyl carbinol. They
also publicized that hydroxymethyl group and long chain
substitutions could possibly produce better features for curing
tumor cells [70].
19. Conclusion
Though many natural components with anti-cancerous charac-
teristicsarepresentandsomeof themareunderclinicaltrialsbutstill
the interest in this part of research is not enough may be due to the
reasons of considering natural products less liable to patent-ship.
Exploring land and ocean can provide us with the solution to our
medical problems if attention is paid toward them.Useof edible and
non-edible plants constituents with computational tools to design
drugs could enlighten the path toward cancer free approach.
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